Trial intelligence / Profile preview

LPVGenderPK: Sex Differences in Once-Daily Lopinavir/Ritonavir PK

NCT00148759Phase 4Completed

Sponsor
Emory University
Start
Jun 2005
Primary completion
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Emory University. Started Jun 2005; status: completed.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00148759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00148759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call